I can take this one, Matt. So, Gray, just to maybe take a step back. And so -- when you look at the ARR over the last couple of quarters, ending 8% growth this quarter, that deceleration, I would say, is primarily related to, again, the taking longer -- the sales and marketing taking longer, which obviously has impacted -- part of it is the macro as well, but it’s partly that. The other component that I will mention as well is the product sunsetting, right? That has an impact. That’s about 2% on that 8% that has had an impact on. The other component, we mentioned this in the last 2 or 3 calls as well, which is the couple of larger clients that contracted, primarily in Q3. So, you’ll see that for another quarter or so. And then to a lower extent, I would say, but also important to mention is due to the macro, some of the verticals, particularly in the DA business, in this case insurance and mortgage continue to see that sort of like lower levels compared to the last few quarters. And so that also, again, driven by the macro, but as well, particularly impacting those verticals. And then one of the things just to mention as well is, I mentioned about the macro deals currently increasing. We saw that more pronounced in Q2, particularly in DA. One of the deals that slipped that Matt mentioned, slipped from Q2 into Q3, that deal, a 2 million ACV deal, that would have added another 1.5 points to it. And so I think it’s a combination of both, Gray, but I think it’s sort of like equally macro, but also the sales and marketing engine taking lower than anticipated also is dampening that growth.